Description of blood Analysis: 

Erythropoietin (EPO) is a glycoprotein hormone produced primarily by the interstitial cells of the kidneys (and in smaller amounts by the liver). Its fundamental role is to regulate the production of red blood cells (erythrocytes) in the bone marrow. When oxygen levels in the blood drop—a condition known as hypoxia—the kidneys increase EPO production, which signals the bone marrow to accelerate the creation of new red cells to improve oxygen transport. In clinical diagnostics, measuring EPO levels is essential for determining the underlying cause of various blood disorders. It helps distinguish between conditions where the body is failing to produce enough cells (anemia) and conditions where it is producing too many (polycythemia).

What does the analysis represent?

• Purpose: To quantify the hormone that controls the rate of red blood cell synthesis.
• Primary Application: Investigating the cause of anemia (especially in chronic kidney disease), distinguishing between primary and secondary polycythemia, and detecting EPO-secreting tumors.
• Method: Chemiluminescent immunoassay (CLIA) or ELISA using a venous blood sample.

Recommendations for the Test (General)

• Timing: It is recommended to have the blood drawn in the morning, as EPO levels can exhibit a mild diurnal rhythm.
• Fasting: Not required; water permitted.
• Rest: Avoid intense physical exertion for 24 hours before the test, as strenuous activity can temporarily alter oxygen demand and EPO levels.
• Specific Rules: Refrain from alcohol consumption for 24 hours. Inform your doctor if you have recently spent time at high altitudes, as this naturally elevates EPO.

What can affect the results?

• Factors altering levels: Pregnancy, high-altitude living, and chronic lung disease naturally increase EPO. Conversely, chronic kidney disease often leads to a deficiency, as the kidneys lose their ability to produce the hormone.
• Conversely: The use of performance-enhancing drugs (synthetic EPO) or recent blood transfusions will significantly suppress natural EPO levels.

When to take the test?

• Recommendations: This test is requested when a patient has an abnormal Red Blood Cell (RBC) count, hemoglobin, or hematocrit on a standard blood test, or when a physician needs to monitor the response to EPO replacement therapy.
• Preparation: The test should be scheduled when the patient is in a stable clinical state. It is often performed alongside a Complete Blood Count (CBC) and Reticulocyte count for a full assessment.

How to interpret the results?

• The interpretation of your laboratory results is the exclusive responsibility of a qualified physician.
• An EPO value must always be interpreted in the context of the patient’s hemoglobin level. For example, low EPO in the presence of anemia suggests a kidney problem, while low EPO in the presence of too many red cells suggests Polycythemia Vera.
• Only a professional medical review can integrate these findings with your clinical history to determine if bone marrow or kidney issues are present.

Possible further investigations

• Complete Blood Count (CBC): To evaluate current hemoglobin and hematocrit levels.
• Reticulocyte Count: To see how many “young” red blood cells the bone marrow is actually producing.
• Serum Ferritin and Vitamin B12: To rule out nutritional deficiencies as a cause of anemia.
• Hematology or Nephrology Consultation: To develop a treatment plan for blood or kidney-related disorders.

When does the next step make sense?

• If EPO levels are found to be inappropriately low or high, the findings are reviewed by a physician to decide on treatments such as EPO injections or further testing for bone marrow disorders (like the JAK2 mutation).
• All medical decisions are personalized based on the patient’s oxygenation status and kidney health.

👉 If necessary, you can discuss the analysis results with a specialist such as a hematologist (Doctors – TAMC) or a nephrologist (Doctors – TAMC).